… Filip De Keyser Filip De Keyser … Jean-François Rahier, Michel Moutschen, Alfons Van
Gompel, Marc Van Ranst, Edouard Louis, Siegfried Segaert, Pierre Masson, Filip De Keyser, …

Introduction Systemic sclerosis (SSc) is an autoimmune connective tissue disorder
characterized by fibroproliferative vasculopathy, immunological abnormalities and progressive …

… Filip De Keyser Filip De Keyser 1 Erasmus MC, University Medical Center Rotterdam,
Rotterdam, The Netherlands, 2 de Duve Institute, Université Catholique de Louvain, Brussels, 3 …

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and
internal organs that leads to profound disability and premature death. To identify new SSc …

… F De Keyser1 … This work was supported by a grant from the ‘Vlaams instituut voor de
bevordering van het wetenschappelijk-technologisch onderzoek in de industrie’ (IWT/SB/11127) …

Objective To confirm in a placebo‐controlled trial the safety and efficacy profile of infliximab
in short‐term treatment of patients with active spondylarthropathy (SpA). Methods Forty …

Background Plasmacytoid dendritic cells have been implicated in the pathogenesis of
systemic sclerosis through mechanisms beyond the previously suggested production of type I …

Objective To determine the overall prevalence of spondyloarthropathy (SpA) among patients
with inflammatory bowel disease (IBD)[Crohn's disease (CD) and ulcerative colitis (UC)]. …

… Filip de Keyser Filip de Keyser … Rather, the D1·D2 and E·F·G complexes first bind to the Sm
site, thus forming a so-called subcore snRNP intermediate. Subsequent association of the B/B…

At present only few biological data are available to indicate whether psoriatic arthritis (PsA)
is part of the spondyloarthropathy (SpA) concept, whether it is a separate disease entity or a …